AviadoBio Ltd

1 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) (NCT06064890)	AviadoBio Ltd	2023-08-30

Every clearance here is in the API, with alerts when new ones post.